Jae Sevelius, PhD (Emeritus)

Headshot of Jae Sevelius
User Profile Photo

Jae Sevelius, PhD (Emeritus)

User Profile Name
Director, Center for AIDS Prevention Studies (CAPS)
Professor, School of Medicine
User Profile Title
User Profile Email

Biography

Jae Sevelius, PhD, is a licensed clinical psychologist whose research focuses on the investigation of risk and protective factors in transgender and gender diverse communities and relationships between intersectional stigma, gender affirmation, and health-related behaviors and outcomes. Most recently, Dr. Sevelius’ research has focused on developing and testing peer-led interventions to promote sexual health and resilience among transgender people by addressing intersectional stigma among transgender women of color and those affected by HIV.

Dr. Sevelius is Director of the Center for AIDS Prevention Studies (CAPS), Co-Director of the CAPS Developmental Core, and PI and co-founder of the Center of Excellence for Transgender Health.

User Profile Bio

Displaying 26 - 50 of 86

  1. Blackstock OJ, Platt J, Golub SA, Anakaraonye AR, Norton BL, Walters SM, Sevelius JM, Cunningham CO. A Pilot Study to Evaluate a Novel Pre-exposure Prophylaxis Peer Outreach and Navigation Intervention for Women at High Risk for HIV Infection. AIDS Behav. 2021 May; 25(5):1411-1422.
  2. Auerbach JD, Moran L, Weber S, Watson C, Keatley J, Sevelius J. Implementation Strategies for Creating Inclusive, All-Women HIV Care Environments: Perspectives From Trans and Cis Women. Womens Health Issues. 2021 Jul-Aug; 31(4):332-340.
  3. Sevelius JM, Chakravarty D, Dilworth SE, Rebchook G, Neilands TB. Measuring Satisfaction and Comfort with Gender Identity and Gender Expression among Transgender Women: Development and Validation of the Psychological Gender Affirmation Scale. Int J Environ Res Public Health. 2021 03 23; 18(6).
  4. Vance SR, Boyer CB, Glidden DV, Sevelius J. Mental Health and Psychosocial Risk and Protective Factors Among Black and Latinx Transgender Youth Compared With Peers. JAMA Netw Open. 2021 03 01; 4(3):e213256.
  5. D'Avanzo PA, Bass SB, Kelly PJ, Brajuha J, Gutierrez-Mock L, Sevelius J. Community Belonging and Attitudes Towards HIV Pre-Exposure Prophylaxis (PrEP) Among Transgender Women. AIDS Behav. 2021 Sep; 25(9):2728-2742.
  6. Poteat TC, van der Merwe LLA, Sevelius J, Keatley J. Inclusion as illusion: erasing transgender women in research with MSM. J Int AIDS Soc. 2021 01; 24(1):e25661.
  7. Sevelius JM, Chakravarty D, Dilworth SE, Rebchook G, Neilands TB. Gender Affirmation through Correct Pronoun Usage: Development and Validation of the Transgender Women's Importance of Pronouns (TW-IP) Scale. Int J Environ Res Public Health. 2020 12 19; 17(24).
  8. Sauceda, J.A., Santiago-Rodriguez, E.I., Zaragoza, G., Rivas, C.E., Venegas, L., Zamudio-Haas, S., Gutierrez-Mock, L., Bass, S.B., Sevelius, JM . Housing stability and transactional sex among Spanish-speaking and English-speaking transgender women. Annals of LGBTQ+ Public and Population Health. 2020.
  9. Gamarel KE, Sevelius JM, Neilands TB, Kaplan RL, Johnson MO, Nemoto T, Darbes LA, Operario D. Couples-based approach to HIV prevention for transgender women and their partners: study protocol for a randomised controlled trial testing the efficacy of the 'It Takes Two' intervention. BMJ Open. 2020 10 15; 10(10):e038723.
  10. Williams, M. T., Bartlett, A., Michaels, T., Sevelius, J., & George, J. R.. Dr. Valentina Wasson: Questioning what we think we know about the foundations of psychedelic science. Journal of Psychedelic Studies. 2020.
  11. Suen LW, Lunn MR, Katuzny K, Finn S, Duncan L, Sevelius J, Flentje A, Capriotti MR, Lubensky ME, Hunt C, Weber S, Bibbins-Domingo K, Obedin-Maliver J. What Sexual and Gender Minority People Want Researchers to Know About Sexual Orientation and Gender Identity Questions: A Qualitative Study. Arch Sex Behav. 2020 10; 49(7):2301-2318.
  12. Auerbach JD, Moran L, Watson C, Weber S, Keatley J, Sevelius J. We Are All Women: Barriers and Facilitators to Inclusion of Transgender Women in HIV Treatment and Support Services Designed for Cisgender Women. AIDS Patient Care STDS. 2020 09; 34(9):392-398.
  13. Gamarel KE, Sevelius JM, Neilands TB, Kaplan RL, Johnson MO, Nemoto T, Darbes LA, Operario D. Couples-based approach to HIV prevention for transgender women and their partners: study protocol for a randomised controlled trial testing the efficacy of the 'It Takes Two' intervention. BMJ Open. 2020 10 15; 10(10):e038723.
  14. Auerbach, J., Moran, L., Watson, C., Weber, S., Keatley, J., Sevelius, J.. We Are All Women: Barriers and facilitators to inclusion of transgender women in HIV treatment and support services designed for cisgender women. AIDS Patient Care and STDs. 2020.
  15. Sevelius JM, Neilands TB, Dilworth S, Castro D, Johnson MO. Sheroes: Feasibility and Acceptability of a Community-Driven, Group-Level HIV Intervention Program for Transgender Women. AIDS Behav. 2020 May; 24(5):1551-1559.
  16. Wiklund, L. O., Anderson-Carpenter, K. D., Sevelius, J. M., Ching, T., & Buchanan, N. T.. Translating research into practice to close the health disparity gap in the LGBTQIA+ community. Annals of Behavioral Medicine. 2020; (54):S451-S45.
  17. Grant RM, Pellegrini M, Defechereux PA, Anderson PL, Yu M, Glidden DV, O'Neal J, Yager J, Bhasin S, Sevelius J, Deutsch MB. Sex Hormone Therapy and Tenofovir Diphosphate Concentration in Dried Blood Spots: Primary Results of the iBrEATHe Study. Clin Infect Dis. 2020 Aug 08.
  18. MacPhail C, Khoza N, Treves-Kagan S, Selin A, Gómez-Olivé X, Peacock D, Rebombo D, Twine R, Maman S, Kahn K, DeLong SM, Hill LM, Lippman SA, Pettifor A. Process elements contributing to community mobilization for HIV risk reduction and gender equality in rural South Africa. PLoS One. 2019; 14(12):e0225694.
  19. Conroy AA, Ruark A, McKenna SA, Tan JY, Darbes LA, Hahn JA, Mkandawire J. The Unaddressed Needs of Alcohol-Using Couples on Antiretroviral Therapy in Malawi: Formative Research on Multilevel Interventions. AIDS Behav. 2020 Jun; 24(6):1599-1611.
  20. Sevelius JM, Neilands TB, Dilworth S, Castro D, Johnson MO. Sheroes: Feasibility and Acceptability of a Community-Driven, Group-Level HIV Intervention Program for Transgender Women. AIDS Behav. 2020 May; 24(5):1551-1559.
  21. Wiklund, L. O., Anderson-Carpenter, K. D., Sevelius, J. M., Ching, T., & Buchanan, N. T.. Translating research into practice to close the health disparity gap in the LGBTQIA+ community. Annals of Behavioral Medicine. 2020; (54):S451-S45.
  22. George, J.R., Michaels, T.I., Sevelius, J.M., Williams, M. . The Psychedelic Renaissance and the limitations of a White-dominant medical framework. Journal of Psychedelic Studies. 2019.
  23. Callander D, Schneider JA, Radix A, Chaix B, Scheinmann R, Love G, Smith J, Regan SD, Kawachi I, St James K, Ransome Y, Herrera C, Reisner SL, Doroshow C, Poteat T, Watson K, Bluebond-Langner R, Toussaint N, Garofalo R, Sevelius J, Duncan DT. Longitudinal cohort of HIV-negative transgender women of colour in New York City: protocol for the TURNNT ('Trying to Understand Relationships, Networks and Neighbourhoods among Transgender women of colour') study. BMJ Open. 2020 04 01; 10(4):e032876.
  24. Sevelius, J. . Psychedelic-Assisted Therapy with Transgender and Gender Diverse Individuals. Bulletin of the Multidisciplinary Association for Psychedelic Studies, Special Edition: Women & Psychedelics. 2019; 1(24):39-42.
  25. Lippman SA, Gilmore HJ, Lane T, Radebe O, Chen YH, Mlotshwa N, Maleke K, Manyuchi AE, McIntyre J. Ability to use oral fluid and fingerstick HIV self-testing (HIVST) among South African MSM. PLoS One. 2018; 13(11):e0206849.